Maze Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MAZE and other ETFs, options, and stocks.About MAZE
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization.
CEOJason V. Coloma
CEOJason V. Coloma
Employees125
Employees125
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2017
Founded2017
Employees125
Employees125
MAZE Key Statistics
Market cap1.29B
Market cap1.29B
Price-Earnings ratio-17.67
Price-Earnings ratio-17.67
Dividend yield—
Dividend yield—
Average volume374.66K
Average volume374.66K
High today$31.93
High today$31.93
Low today$29.10
Low today$29.10
Open price$29.97
Open price$29.97
Volume280.00K
Volume280.00K
52 Week high$31.93
52 Week high$31.93
52 Week low$6.71
52 Week low$6.71
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MAZE. This list is generated using Robinhood data, and it’s not a recommendation.